biomarker-trends-header.png

Myriad's True Value

Some interesting points raised in a NY Times editorial yesterday regarding Myriad's true underlying value being in its database of mutations. In a paper referenced by the editorial the authors describe Myriad's database of BRCA1/2 mutations and the value of the company's ability to understand the ...

Reporting rates for clinical trials

Unmasking 'Invisible' Drug Trials - ScienceInsider.

   

March

Webinar: 

Pharmacovigilance and Safety Biomarkers

RECORDING
New Call-to-action
FREE REPORT

Subscribe for Updates

Download our Free IVD Trends Report